Select a Size
| Size/SKU | Availability | Price |
|---|---|---|
100 μg | Check Cart for Availability | 1.850,00 PLN |
About This Item
biological source
rabbit
Quality Segment
conjugate
unconjugated
antibody form
affinity isolated antibody
antibody product type
primary antibodies
clone
polyclonal
purified by
affinity chromatography
species reactivity
human
concentration
1 mg/mL
technique(s)
immunohistochemistry: suitable (paraffin), western blot: suitable
NCBI accession no.
UniProt accession no.
shipped in
wet ice
target post-translational modification
unmodified
Gene Information
human ... VEGFB(7423)
General description
Immunogen
Application
Apoptosis & Cancer
Apoptosis - Additional
Physical form
Preparation Note
Analysis Note
Western Blotting Analysis: 1.0 µg/mL of this antibody detected VEGF-B in 10 µg of human skeletal muscle tissue lysate.
Disclaimer
1 of 1
This Item | |||
|---|---|---|---|
| description 1 mg/mL, from rabbit | description 1 mg/mL, from rabbit | description IgG fraction of antiserum, buffered aqueous solution | description from rabbit, purified by affinity chromatography |
| conjugate unconjugated | conjugate unconjugated | conjugate - | conjugate unconjugated |
| biological source rabbit | biological source rabbit | biological source rabbit | biological source rabbit |
| antibody form affinity isolated antibody | antibody form affinity isolated antibody | antibody form IgG fraction of antiserum | antibody form affinity isolated antibody |
| Quality Level 100 | Quality Level 100 | Quality Level 100 | Quality Level 100 |
| clone polyclonal | clone polyclonal | clone polyclonal | clone polyclonal |
| UniProt accession no. | UniProt accession no. | UniProt accession no. | UniProt accession no. |
Still not finding the right product?
Try our Product Selector Tool to narrow your options
Storage Class
12 - Non Combustible Liquids
WGK
WGK 1
Choose from one of the most recent versions:
Already Own This Product?
Find documentation for the products that you have recently purchased in the Document Library.



